Drug and Pharmacology Database
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- HT001125RFI0225
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- Not on record
- Place of performance
- Falls Church, Virginia, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency (DHA) is seeking a comprehensive clinical and dental drug and pharmacology database for military medical personnel across the Department of Defense. This commercial off-the-shelf (COTS) digital resource will serve medical professionals in Air Force, Army, Navy, and Coast Guard Medicine, providing extensive drug information, guidance, and references. The RFI aims to identify vendors capable of delivering a first-line drug reference resource with robust technical capabilities, including web and mobile access, offline functionality, and integration with DoD Electronic Health Record systems. Interested parties must submit detailed responses by 12:00 PM on April 1, 2025, to Contracting Officer Jeanna Butler and Contract Specialist Theophilus Agyare. The government will evaluate potential vendors based on their organizational capacity, financial resources, project management capabilities, and technical competence to perform under a performance-based service acquisition contract.
The contract opportunity is currently not set aside for any specific business classification, though small businesses may be considered. The base contract is structured for a one-year period from August 1, 2025, to July 31, 2026, with four additional one-year option periods and a potential six-month extension. The database must support up to 2.5 million IP addresses, provide unlimited simultaneous user access, and offer 24/7/365 technical support. Key technical requirements include mobile apps for iOS and Android with full offline functionality, compatibility with multiple authentication solutions, and the ability to provide specialized content such as pharmacogenomics sections, infectious disease references, and multilingual patient education materials. While specific award value is not disclosed, the comprehensive nature of the requirements suggests a significant contract with potential for multiple vendor awards.
Notice text
2 versions
Update #2 · Latest ·
Amendment 0001 issued on 19 March 2025.
The purpose of amendment 0001 is to:
1. Attach the draft statement of work for the Drug and Pharmacology Database requirement.
2. Extend the response due date to 01 April 2025 at 12:00 PM EDT.
Please find attached details of RFI number HT001125RFI0225 for Drug and Pharmacology Database.
Update #1 ·
Please find attached details of RFI number HT001125RFI0225 for Drug and Pharmacology Database.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Drug and Pharmacology Database | Award Notice | |
| Drug and Pharmacology Database | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| RFI for Data Hosting, Integration, and Sustainment Support for the OBHAT/BHAS Program | — | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity